Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury.

Bader, Miaad et al.·Neurobiology of disease·2019·
RPEP-040612019RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury.
Published In:
Neurobiology of disease, 124, 439-453 (2019)
Database ID:
RPEP-04061

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-04061·https://rethinkpeptides.com/research/RPEP-04061

APA

Bader, Miaad; Li, Yazhou; Lecca, Daniela; Rubovitch, Vardit; Tweedie, David; Glotfelty, Elliot; Rachmany, Lital; Kim, Hee Kyung; Choi, Ho-Il; Hoffer, Barry J; Pick, Chaim G; Greig, Nigel H; Kim, Dong Seok. (2019). Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury.. Neurobiology of disease, 124, 439-453. https://doi.org/10.1016/j.nbd.2018.11.023

MLA

Bader, Miaad, et al. "Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury.." Neurobiology of disease, 2019. https://doi.org/10.1016/j.nbd.2018.11.023

RethinkPeptides

RethinkPeptides Research Database. "Pharmacokinetics and efficacy of PT302, a sustained-release ..." RPEP-04061. Retrieved from https://rethinkpeptides.com/research/bader-2019-pharmacokinetics-and-efficacy-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.